56例拖吡酯不良反应文献及临床病例分析

摘要/Abstract

摘要： 目的了解托吡酯致不良反应一般规律及特点,为托吡酯临床安全合理使用提供参考。方法本研究纳入自1999年3月至2018年3月应用托吡酯出现药品不良反应（ADR）并上报至首都医科大学附属北京天坛医院药剂科的患者,同时检索以上时间段中国期刊网全文数据库、万方数据库、维普中文期刊全文数据库、中国生物医学文献数据库中报道的中国患者的文献,按照纳入与排除标准筛选出文献,统计相应的ADR信息,将我院患者及通过文献提取出的病例信息合并后进行归纳分析。结果不良反应多发生在18岁以下患者,原患疾病主要为癫痫,不良反应多发生于用药后1~3个月内,累及系统-器官损害主要为神经系统损害和皮肤及其附件系统损害等,临床表现以认知障碍和出汗减少最为常见,其次为厌食和体重下降,共有10例次严重ADR,其中皮肤及其附件占比最多,其次为泌尿系统损害,无死亡病例,经减、停托吡酯后症状多能痊愈或缓解。结论在应用托吡酯时需关注患者有无过敏史、肾结石家族史等,从小剂量开始,缓慢加量,并监测血常规、肝功能、血氨、电解质、泌尿系B超等,一旦出现ADR表现应尽早诊断及治疗,保障安全用药。

关键词: 托吡酯, 药品不良反应, 文献分析

Abstract: Objective Through investigating the characteristics and mechanism of adverse reactions induced by topiramate, to find its risk factors and provide technical support for safe and rational use of drugs in clinic. Methods The patients who experienced adverse drug reactions(ADRs) induced by topiramate and reported by the department of pharmacy in Beijing Tiantan Hospital from March 1999 to March 2018 were included. At the same time articles in the CNKI database, Wanfang database, VIP Chinese full-text database and CBM database were searched, and the patients in the references which met the inclusion criteria were extracted. Then the ADR information of the patients both from Beijing Tiantan Hospital and the literatures were analyzed together. Results Most of the reactions occurred in patients under the age of 18. The major illness was epilepsy. ADRs occurred more frequently within 1 to 3 months after topiramate treatment. Systems and organs mainly involved in adverse reactions were neurological disorders, skin and appendages disorders, etc. Cognitive disorders and hypohidrosis were the most commonly reported adverse reactions, followed by anorexia and weight decrease. There were ten serious ADRs among which skin and appendages disorders were the most common, and then urinary tract disorders. No case died because of ADRs induced by topiramate, and most ADRs were fully recovered or relieved by stopping or reducing the use of topiramate. Conclusion The family history of nephrocalcinosis and allergy history should be asked before using topiramate. Start using topiramate with a small dose and increase the dose slowly. Blood routine test、liver function、ammonia、electrolyte、urinary system ultrasound test of patients should be monitored. Once ADRs occur, diagnosis and treatment should be carried out as soon as possible to ensure the safe drug use.

Key words: topiramate, adverse drug reactions, literature review

中图分类号:

R994.11

郭芒芒, 孟进, 庄洁, 杨伟力, 高宝勤, 邓亚仙. 56例拖吡酯不良反应文献及临床病例分析[J]. 中国药物警戒, 2018, 15(7): 434-439.

GUO Mangmang, MENG Jin, ZHUANG Jie, YANG Weili, GAO Baoqin, DENG Yaxian. Analysis of 56 Literature and Clinical Cases of Adverse Reactions Induced by Topiramate[J]. Chinese Journal of Pharmacovigilance, 2018, 15(7): 434-439.

参考文献

[1] Shank R P, Gardocki J F, Vaught J L, et al.Topiramate: preclinical evaluation of structurally novel anticonvulsant[J]. Epilepsia, 1994,35(2):450-460.
[2] 阮雯聪, 陈彤, 李海峰. 托吡酯诱发高氯血症1例[J]. 浙江实用医学, 2017,22(2):153.
[3] 蒋晗, 郝南亚, 宋春江,等. 托吡酯治疗导致成人癫痫患者尿失禁二例[J]. 华西医学, 2016,31(12):2090-2091.
[4] 陈亚南, 张媞, 徐善森, 等. 丙戊酸钠联用新型抗癫痫药对癫痫患儿血氨的影响[J]. 中国临床药理学杂志, 2016,32(15):1378-1380.
[5] 苏学宁, 徐梅松, 王欢, 等. 托吡酯导致高氨血症1例报告[J]. 中风与神经疾病, 2015,32(5):463.
[6] 杨诺, 张波, 郝云鹏, 等. 托吡酯治疗儿童Sturge-Weber综合征继发癫痫后并发青光眼1例[J]. 中国当代儿科杂志, 2014,16(3):315-316.
[7] 袁粤, 章群. 托吡酯致老年人剥脱性皮炎1例[C]// 2013浙江省医学会精神病学分会学术年会暨浙江省医师协会精神科医师分会年会. 2013.
[8] 刘永红, 李力, 李小宁, 等. 部分性癫痫间持续状态的诊治(附3例病例随访研究)[J]. 卒中与神经疾病, 2013,20(1):27-28.
[9] 熊勋波, 王宗喜. 托吡酯致剥脱性皮炎1例[J]. 中国医院药学杂志, 2012,32(3):239-240.
[10] 王丽平, 李永辉. 托吡酯致红细胞减少一例[J]. 中国医药, 2011,6(2):226. [11] 汪春运. 托吡酯减轻精神药物引起的体重增加1例[J]. 四川精神卫生, 2011,24(1):11.
[12] 汪春运. 托吡酯与尿路结石相关联1例报告[J]. 四川精神卫生, 2011,24(3):135.
[13] 罗晓波, 伍建红. 托吡酯致反复尿路结石1例[J]. 中国医院用药评价与分析, 2011,11(6):575-576.
[14] 刘训斌, 李学军, 刘玉兰. 2例重症药疹病例的药学监护[J]. 中南药学, 2009,7(11):870-872.
[15] 谢小英. 托吡酯致心肌损害1例[J]. 中国保健, 2008,16(25):945.
[16] 毛开新, 孙艳萍, 周雄飞, 等. 托吡酯致心肌损害9例临床分析[J]. 实用医学杂志, 2008,24(3):457-458.
[17] 魏京海. 儿童应用新型抗癫痫药不良反应报告及分析[C]// 全国儿科药学学术会议. 2008.
[18] 林彩梅, 庄嘉鑫, 饶立德. 托吡酯致共济失调二例报告[J]. 临床误诊误治, 2007,20(12):86-87.
[19] 郑锦萍. 妥泰引起的认知障碍[C]// 全国内科急危重病医学. 2007.
[20] 陈显光, 何文贞, 徐巧玉. 妥泰治疗病毒性脑炎继发癫痫的临床观察(附1例报告)[J]. 实用中西医结合临床, 2007,7(3):5-6.
[21] 庄婉莉, 林广裕, 郑红. 托吡酯致严重失眠3例报告[J]. 中南药学, 2006,4(5):396.
[22] 马榕, 邵彦, 周明. 妥泰致黄斑区视网膜改变1例[J]. 中国实用眼科杂志, 2006,24(2):141.
[23] 宋凡. 托吡酯治疗发作性运动诱发性肌张力障碍2例报告[C]// 第九次全国神经病学学术大会论文汇编. 2006.
[24] 孙伟, 王薇薇, 吴逊. 妥泰引起严重认知障碍[J]. 中国康复理论与实践, 2005,11(5):402-403.
[25] 徐萍. 托吡酯致全身过敏性皮疹1例[J]. 中国新药杂志, 2004,13(3):242.
[26] 龙冬兰, 沈亦辉. 口服托吡酯出现一过性痴呆1例[J]. 中国新药与临床杂志, 2004,23(9):645-646.
[27] 湛月娥, 王丹. 口服托吡酯(妥泰)出现长期发热遗尿1例[J]. 儿科药学杂志, 2004,10(6):58-59.
[28] 张华芸, 郗梅. 托吡酯口服致小儿反复发热[J]. 药物不良反应杂志, 2003,5(2):116.
[29] 梁煊芝. 托吡酯治疗难治性癫痫临床观察[J]. 中华医药学杂志, 2003,2(4):95-96.
[30] 姚朝亚, 丁新生, 李晓波. 托吡酯治疗癫痫出现自身免疫性溶血性贫血1例报告[J]. 临床神经病学杂志, 2003,16(3):180.
[31] 高晨. 托吡酯致小儿反复发热[J]. 药物不良反应杂志, 2002,4(2):126.
[32] 赵贵芳, 杨晓东, 徐成敏, 等. 碳酸锂合并托吡酯致中毒一例[J]. 中华精神科杂志, 2002,35(3):156.
[33] 蔡少华. 妥泰引起卡马西平血药浓度下降1例报告[J]. 药学实践杂志, 2002,20(5):304.
[34] 王家勤. 托吡酯治疗脑性瘫痪并癫痫[J]. 中华实用儿科临床杂志, 2002,17(3):202-203.
[35] 金卫东. 妥泰治疗2例双相情感性障碍的疗效报告[J]. 四川精神卫生, 2002,15(1):50.
[36] 邵亚琴. 托吡酯致药物性皮疹1例[J]. 中国医院药学杂志, 2001,21(9):574.
[37] 黄志民. 托吡酯致儿童无汗症2例[J]. 中国神经精神疾病杂志, 2001,27(5):391-392.
[38] 杨铁金. 妥泰致泌尿系统结石1例[J]. 海峡药学, 2000,12(3):111-112.
[39] 李春元. 托吡酯与暴发性肝衰竭[J]. 国外医学药学分册, 1999,26(2):55-56.
[40] 吴桂芝, 田春华, 王丹, 等. WHOART和MedDRA在药品不良反应监测中的应用[J]. 中国药物警戒, 2010,7(2):81-85.
[41] 张夏兰, 沈夕坤, 缪洁. 某院儿科门诊超说明书用药情况调查[J]. 中国药物警戒, 2017,14(9):562-565.
[42] 蔡浅云, 罗蓉, 吴惧, 等. 四川地区新型抗癫痫药物超说明书规定用药分析:一项对儿童患者的多中心调查研究[J]. 中国现代神经疾病杂志, 2012,12(5):536-541.
[43] Grosso S, Galimberti D, Farnetani M A, et al.Efficacy and safety of topiramate in infants according to epilepsy syndromes[J]. Seizure European Journal of Epilepsy, 2016,14(3):183-189.
[44] Zhu X, Chen O, Zhang D, et al.A prospective study on the treatment of infantile spasms with first-line topiramate followed by low-dose ACTH[J]. Epilepsy Research, 2011,93(2-3):149-154.
[45] Silverstein F S, Ferriero D M.Off-label use of antiepileptic drugs for the treatment of neonatal seizures[J]. Pediatric Neurology, 2008,39(2):77-79.
[46] Korinthenberg R, Schreiner A.Topiramate in children with west syndrome: a retrospective multicenter evaluation of 100 patients[J]. Journal of Child Neurology, 2007,22(3):302.
[47] 张春红, 张秀华, 郑荣远. 托吡酯的不良反应[J]. 中国临床药学杂志, 2003,3(4):209-210.
[48] 王玉珍, 庞保东, 刘寅. 儿童难治性癫痫多药治疗及药物相互作用的研究进展[J]. 药学服务与研究, 2010,10(4):282-285.
[49] 李朝霞, 孙若鹏, 孙昭辉, 等. 丙戊酸对癫痫患儿血浆氨水平的影响[J]. 中国实用儿科杂志, 2007,22(11):862-863.
[50] Latour P, Biraben A, Polard E, et al.Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both?[J]. Human Psychopharmacology Clinical & Experimental, 2004,19(3):193-203.
[51] Sabers A.Life-threatening adverse events of antiepileptic drugs.[J]. Epilepsy Research, 2001,47(1-2):155.
[52] 楼东东. 妥泰在临床中的应用[J]. 牡丹江医学院学报, 2006,27(4):59-61.
[53] Mégarbane B, Hanak A S, Chevillard L.Lithium-related neurotoxicity despite serum concentrations in the therapeutic range: risk factors and diagnosis[J]. Shanghai Archives of Psychiatry, 2014,26(4):243.
[54] Evins A E.Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders[J]. Journal of Clinical Psychiatry, 2003,64(8):9-14.
[55] 汪春运. 托吡酯在精神科的应用[J]. 中国新药与临床杂志, 2005,24(6):482-485.